Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan J Cornelissen

Showing results (1-10 of 210) with videos related to

Pageof 21
Sort By:
Current Opinion in Hematology|October 4, 2008
Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patientsEllen Meijer, Jan J Cornelissen
Blood|December 15, 2015
Hematopoietic stem cell transplantation for patients with AML in first complete remissionJan J Cornelissen, Didier Blaise
Seminars in Hematology|March 31, 2019
Risks and benefits in a personalized application of allogeneic transplantation in patients with AML in first CRJurjen Versluis, Jan J Cornelissen
Hematology. American Society of Hematology. Education Program|November 24, 2005
Role of allogeneic stem cell transplantation in current treatment of acute myeloid leukemiaJan J Cornelissen, Bob Löwenberg
Seminars in Oncology|August 12, 2008
Allogeneic stem cell transplantation in acute myeloid leukemia in first or subsequent remission: weighing prognostic markers predicting relapse and risk factors for non-relapse mortalityEllen Meijer, Jan J Cornelissen
Blood Reviews|May 6, 2008
Allogeneic stem cell transplantation in acute myeloid leukemia: a risk-adapted approachTom Lodewyck, Jan J Cornelissen
Haematologica|May 22, 2025
It takes two to tango: allogeneic stem cell transplantation and FLT3 tyrosin kinase inhibitor therapyJan J Cornelissen, Jurjen Versluis
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 23, 2003
Clinical utility of tetramer-based immune monitoring in allogeneic stem cell transplantationJan W Gratama, Jan J Cornelissen
Blood Reviews|December 18, 2004
Thymopoiesis following allogeneic stem cell transplantation: new possibilities for improvementEvert-Jan Wils, Jan J Cornelissen
Stem Cell Investigation|June 14, 2017
Graft predominance after double umbilical cord blood transplantation: a reviewJan J Cornelissen, Burak Kalin, Cor H J Lamers
Pageof 21

Showing results (1-10 of 210) with videos related to

Sort By:
Pageof 21
Current Opinion in Hematology|October 4, 2008
Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patientsEllen Meijer, Jan J Cornelissen
Blood|December 15, 2015
Hematopoietic stem cell transplantation for patients with AML in first complete remissionJan J Cornelissen, Didier Blaise
Seminars in Hematology|March 31, 2019
Risks and benefits in a personalized application of allogeneic transplantation in patients with AML in first CRJurjen Versluis, Jan J Cornelissen
Hematology. American Society of Hematology. Education Program|November 24, 2005
Role of allogeneic stem cell transplantation in current treatment of acute myeloid leukemiaJan J Cornelissen, Bob Löwenberg
Seminars in Oncology|August 12, 2008
Allogeneic stem cell transplantation in acute myeloid leukemia in first or subsequent remission: weighing prognostic markers predicting relapse and risk factors for non-relapse mortalityEllen Meijer, Jan J Cornelissen
Blood Reviews|May 6, 2008
Allogeneic stem cell transplantation in acute myeloid leukemia: a risk-adapted approachTom Lodewyck, Jan J Cornelissen
Haematologica|May 22, 2025
It takes two to tango: allogeneic stem cell transplantation and FLT3 tyrosin kinase inhibitor therapyJan J Cornelissen, Jurjen Versluis
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 23, 2003
Clinical utility of tetramer-based immune monitoring in allogeneic stem cell transplantationJan W Gratama, Jan J Cornelissen
Blood Reviews|December 18, 2004
Thymopoiesis following allogeneic stem cell transplantation: new possibilities for improvementEvert-Jan Wils, Jan J Cornelissen
Stem Cell Investigation|June 14, 2017
Graft predominance after double umbilical cord blood transplantation: a reviewJan J Cornelissen, Burak Kalin, Cor H J Lamers
Pageof 21